English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background: Human parvovirus B19 is in emerging transfusion transmitted infection, although parvovirus B19 infection is connected with severe complication in some recipients, donor screening is not yet mandatory. Aim: To determine the prevalence of human parvovirus B19-specific-IgG antibody among blood donors attending the central blood bank (STAC) ,Khartoum State, Sudan, and to determine some possible risk factors. Subjects and Methods: A total of 180 sera samples collected from the participants were screened for human parvovirus B19-specific-IgG antibody using quantitative indirect ELISA technique. Result: Human parvovirus B19-specific-IgG antibodies were detected in 114/180 (63.3%). No statistical significance was determined regarding the variables tested in this study and the results of human parvovirus B19- specific-IgG antibody detection. Conclusion: Blood donors might be a source of infection with this virus. These findings form a solid base for further studies on confirming the presence of human parvovirus B19 in donor sera. It should be considered by the ministry of health and blood banks to develop new policies for blood screening.

Seroprevalance of Human Parvovirus B19 among Blood Donor Volunteers from Sudanese Blood Bank in Khartoum State 2017